Manufacturing Biopharmaceutical Contract Manufacturing / Biomanufacturing Services

Cambrex Breaks Ground on $120M Charles City Expansion
Thursday, November 05, 2026
Cambrex has broken ground on a $120 million expansion at its Charles City, Iowa facility. The project will add 160,000 liters of manufacturing capacity, increasing the site's total capacity by approximately 25% to nearly one million liters. read more
Alcami Promotes Robert Tragas to VP, Laboratory Services
Thursday, November 05, 2026
Alcami has promoted Robert Tragas to Vice President, Laboratory Services. In his expanded role, Tragas will lead laboratory operations across the CDMO's Research Triangle Park campus, overseeing analytical, biologics, microbiology and environmental monitoring functions. read more
Samsung Biologics Earns 'Negligible Risk' ESG Rating
Thursday, November 05, 2026
Samsung Biologics has achieved a 'Negligible Risk' rating in the latest Morningstar Sustainalytics ESG Risk Ratings assessment. The CDMO received an ESG Risk Rating score of 9.0, advancing from its previous 'Low Risk' rating to 'Negligible Risk,' the lowest of five risk categories. read more
Pyramid Pharma Services Adds 13th Commercial Product
Thursday, November 05, 2026
Pyramid Pharma Services has expanded a partnership with a longstanding biopharmaceutical customer to manufacture its 13th commercial product: a cartridge-based presentation of a therapy approved to treat rare blood cancers. read more
Support your ADC program progression with expert insight
Wednesday, November 04, 2026
ADCs are transforming cancer therapy but manufacturing them is complex. Pfizer CentreOne's experts share actionable insights to help accelerate your program. Download the whitepaper today. read more

More News

A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Layoffs and Mergers & Acquisitions - Plus Long COVID Study ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: In this week’s Pharma Flash – Emergent cuts business operations and reduces headcount. PrecisionLife releases COVID study results and Lilly and Regeneron...